Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 study of ChAdOx1 RVF vaccine in healthy adults and adolescents in Senegal
PACTR202604661114270Phase 1Not yet recruiting
- Sponsor
- Institut Pasteur de Dakar
- Start
- Jul 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial in Rift Valley fever (RVF) (2 arms), sponsored by Institut Pasteur de Dakar. Planned start Jul 2026; status: not yet recruiting.
02
Conditions
Rift Valley fever (RVF)
Beyond the preview
Go deeper on PACTR202604661114270.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202604661114270.